<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The TP53 homolog p73 is structurally and functionally similar to TP53 and plays an important role in modulating cell-cycle control, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and cell growth </plain></SENT>
<SENT sid="1" pm="."><plain>G4C14-to-A4T14 is the most commonly studied polymorphism of this gene for its association with risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, but the results are confusing rather than conclusive </plain></SENT>
<SENT sid="2" pm="."><plain>We performed a meta-analysis using 21 eligible studies with a total of 7581 patients and 10,413 controls to summarize the data for an association between the p73 G4C14-to-A4T14 polymorphism and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="3" pm="."><plain>Compared with the common GC/GC genotype, the AT carriers (AT/GC, AT/AT) had a 1.18-fold elevated risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (95% confidence interval [CI]=1.11-1.25, p&lt;0.00001) in a dominant genetic model as estimated in a fixed effect model </plain></SENT>
<SENT sid="4" pm="."><plain>The effect of the G4C14-to-A4T14 polymorphism was further evaluated through stratification analysis </plain></SENT>
<SENT sid="5" pm="."><plain>In four <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> studies, the variant genotypes had a significantly increased risk of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> (odds ratio [OR]=1.16, 95% CI=1.04-1.28, p=0.005) </plain></SENT>
<SENT sid="6" pm="."><plain>Similar phenomena were also found in two <z:hpo ids='HP_0002860'>squamous cell carcinoma</z:hpo> of the head and neck studies (OR=1.32, 95% CI=1.12-1.56, p=0.0010), two <z:e sem="disease" ids="C0153381" disease_type="Neoplastic Process" abbrv="">oral cancer</z:e> studies (OR=1.57, 95% CI=1.26-1.95, p&lt;0.0001), and three <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> studies (OR=1.23, 95% CI=1.01-1.50, p=0.04) </plain></SENT>
<SENT sid="7" pm="."><plain>Increased risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> associated with G4C14-to-A4T14 variant genotypes was pronounced in Caucasians (OR=1.21, 95% CI=1.11-1.31, p&lt;0.00001), the Japanese population (OR=1.24, 95% CI=1.01-1.52, p=0.04), and the Korean population (OR=1.27, 95% CI=1.07-1.52, p=0.007) </plain></SENT>
<SENT sid="8" pm="."><plain>Our meta-analysis suggests that the p73 G4C14-to-A4T14 polymorphism genotypes (GC/AT+AT/AT) may be associated with an increased risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> types and ethnicities </plain></SENT>
</text></document>